184 studies found for:    Open Studies | "Fever"
Show Display Options
Rank Status Study
21 Recruiting Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia
Condition: Febrile Neutropenia
Interventions: Other: Early antibiotic discontinuation;   Other: Usual practice
22 Unknown  Hospital Admissions in Children Aged 3 Months to 5 Years Presenting With Fever to the Emergency Department
Condition: Fever
Intervention:
23 Recruiting Comparison of Temporal to Pulmonary Artery Temperature Measurement in Patients With Fever
Condition: Fever
Intervention:
24 Not yet recruiting Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever
Condition: Familial Mediterranean Fever,
Intervention: Drug: Kineret
25 Unknown  Ibuprofen as a Possible Preventer of Post Bronchoscopy Fever
Condition: Post Bronchoscopy Fever
Intervention: Drug: ibuprofen
26 Recruiting Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014
Condition: Fever
Intervention: Other: text message surveillance for fever
27 Recruiting Celgosivir as a Treatment Against Dengue
Condition: Dengue Fever
Interventions: Drug: celgosivir;   Drug: placebo
28 Unknown  Ibuprofen Suppositories Administration in Infants and Children
Condition: Fever
Intervention: Drug: ibuprofen suppositories
29 Recruiting Laboratory Diagnosis and Prognosis of Severe Dengue
Condition: Dengue Fever
Intervention:
30 Recruiting A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults
Condition: Dengue Fever
Interventions: Biological: 4 µg TDENV-PIV with Alum adjuvant;   Biological: 1 µg TDENV-PIV with AS03B1 adjuvant;   Other: Phosphate buffered saline;   Biological: 1 µg TDENV-PIV with Alum adjuvant;   Biological: 1 µg TDENV-PIV with AS01E1 adjuvant
31 Recruiting A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)
Condition: Dengue Fever
Interventions: Biological: Biological/Vaccine: 4 µg TDENV-PIV with Alum adjuvant;   Biological: Biological/Vaccine: 1 µg TDENV-PIV with AS03B adjuvant;   Other: Phosphate buffered saline;   Biological: 1 µg TDENV-PIV with Alum adjuvant;   Biological: 1 µg TDENV-PIV with AS01E adjuvant
32 Unknown  Orthostatic Hypotension in Children With Acute Febrile Illness
Conditions: Fever;   Orthostatic Hypotension
Intervention: Procedure: All subjects will have their blood pressure measured in supine position (after 5 minute of rest) and after 3 minute of standing.
33 Unknown  Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients
Condition: Familial Mediterranean Fever
Intervention:
34 Recruiting Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and Neutropenia
Condition: Febrile Neutropenia
Interventions: Other: Empirical antimicrobial treatment discontinuation;   Other: Standard empirical antimicrobial treatment discontinuation
35 Recruiting Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures
Condition: Febrile Seizure
Interventions: Drug: Verum arm receiving Carbogen;   Drug: Placebo
36 Recruiting Pediatric FN Definition 2012 Bern
Conditions: Cancer in Children/Adolescents;   Fever in Neutropenia
Intervention:
37 Unknown  Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases
Condition: Febrile Neutropenia
Interventions: Drug: ciprofloxacin;   Drug: cefepime
38 Recruiting Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
Conditions: Febrile Neutropenia;   Cancer;   Breast Cancer;   Ovarian Cancer;   Lung Cancer;   Prostate Cancer;   Multiple Myeloma;   Bladder Cancer;   B-cell Lymphoma
Intervention:
39 Recruiting Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.
Condition: Chemotherapy-induced Febrile Neutropenia
Intervention:
40 Recruiting International Research Consortium on Dengue Risk Assessment, Management, and Surveillance
Condition: Dengue Fever
Intervention: Other: Observation

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years